Two Sigma Investments’s Eledon Pharmaceuticals ELDN Stock Holding History

Two Sigma Investments’s Portfolio ELDN Stock Details ELDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$130K	Buy	+32,945	New	+$120K	﹤0.01%	4857
2023 Q3	–	Sell	-10,586	Closed	-$14.5K	–	3014
2023 Q2	$14.5K	Sell	10,586 -7,000	-40%	-$14.6K	﹤0.01%	2930
2023 Q1	$41.5K	Sell	17,586 -4,051	-19%	-$10.9K	﹤0.01%	2780
2022 Q4	$49.3K	Sell	21,637 -8,100	-27%	-$20K	﹤0.01%	2594
2022 Q3	$82K	Sell	29,737 -1,400	-4%	-$4.46K	﹤0.01%	2255
2022 Q2	$76K	Sell	31,137 -37,349	-55%	-$114K	﹤0.01%	2299
2022 Q1	$270K	Sell	68,486 -56,707	-45%	-$220K	﹤0.01%	2245
2021 Q4	$552K	Buy	125,193 +9,869	+9%	+$49.9K	﹤0.01%	3153
2021 Q3	$713K	Buy	115,324 +57,814	+101%	+$404K	﹤0.01%	2939
2021 Q2	$455K	Buy	57,510 +19,941	+53%	+$188K	﹤0.01%	3186
2021 Q1	$402K	Buy	+37,569	New	+$567K	﹤0.01%	3119

Other funds holding ELDN

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DCM

Defilade Capital Management Emeryville, California $747M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CCM

Catalio Capital Management New York $532M AUM 171.17% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Zimmer Partners New York $4.34B AUM 22.78% 1-Year Est. Return

Two Sigma Investments's ELDN Position: Q2 2026 in Review

Two Sigma Investments opened a new position in Eledon Pharmaceuticals (ELDN) in Q2 2026: 32,945 shares worth $130K. The stake represents ﹤0.01% of the portfolio and ranks #4857 among its holdings. This is a return to the name: Two Sigma Investments previously reported a position in ELDN as recently as Q2 2023.

Two Sigma Investments first reported a position in ELDN in Q1 2021 and has held it in 11 quarters since. The position peaked at $713K in Q3 2021. 161 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

Two Sigma Investments held 32,945 shares of Eledon Pharmaceuticals worth $130K as of Q2 2026.
Eledon Pharmaceuticals was a new Two Sigma Investments position in Q2 2026.
Eledon Pharmaceuticals made up ﹤0.01% of Two Sigma Investments's portfolio in Q2 2026, its #4857 holding.
Two Sigma Investments first reported a position in Eledon Pharmaceuticals in Q1 2021 and has held it in 11 quarters since.
Two Sigma Investments's Eledon Pharmaceuticals position peaked at $713K in Q3 2021.
161 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.